FDA Expands Eligibility for Pfizer COVID Vaccine Booster Dose for Children Ages 5-11

5/17/22 — The FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to authorize the use of a single booster dose for individuals 5 to 11 years of age at least 5 months after completion of a primary series with the Pfizer vaccine. Read the FDA announcement.